Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07254195

Assessment of an Intensive Motor Telerehabilitation Program for Stroke Patients

Intensive Motor Rehabilitation of Stroke Patients: Evaluation of a Telerehabilitation Program

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
51 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery. However, after hospitalization, access to intensive rehabilitation is limited, due to geographical and mobility constraints, and the lack of reimbursement for private occupational therapy. Telerehabilitation, using digital technologies, can overcome these difficulties by offering interactive, accessible rehabilitation at home. Studies show that its effectiveness is comparable to that of clinical rehabilitation. Our study therefore proposes to evaluate the feasibility and effects of a home-based telerehabilitation program using the MindMotion GO device (MindMaze). This 12-week program aims to provide an additional intensive dose of rehabilitation to the standard of care, with 300 minutes of weekly active therapy, planned and monitored remotely by a therapist.

Detailed description

Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery. However, after hospitalization, access to intensive rehabilitation is limited, due to geographical and mobility constraints, and the lack of reimbursement for private occupational therapy. Telerehabilitation, using digital technologies, can overcome these difficulties by offering interactive, accessible rehabilitation at home. Studies show that its effectiveness is comparable to that of clinical rehabilitation. Our study therefore proposes to evaluate the feasibility and effects of a home-based telerehabilitation program using the MindMotion GO device (MindMaze). This 12-week program aims to provide an additional intensive dose of rehabilitation to the standard of care, with 300 minutes of weekly active therapy, planned and monitored remotely by a therapist. It combines synchronous (1time a week with a therapist) and asynchronous (autonomous) sessions. This program is integrated into the post-stroke care pathway by facilitating the transition from hospital to home, without prolonging hospitalization or increasing face-to-face sessions. The study will be a single-center randomized controlled trial, targeting patients in the sub-acute and chronic stages of stroke.

Conditions

Interventions

TypeNameDescription
DEVICETelerehabilitation program using the MindMotion GO deviceIn parallel to the standard of care, patients will participate in a 12-weeks telerehabilitation program using the MindMotion GO device. MindMotion GO is a digital therapy device that offers a catalog of interactive games designed specifically for patients with neurological injuries. During the telerehabilitation program, patients will aim to achieve at least 300 minutes of active therapy per week. They will have 1 synchronous session per week in the clinic or remotely by videoconference with a therapist (PT or OT). Patients are expected to carry out the other planned sessions independently at home. The activity schedule will be drawn up by a remote therapist each week and will be personalized for each patient.

Timeline

Start date
2026-02-25
Primary completion
2028-01-25
Completion
2028-01-25
First posted
2025-11-28
Last updated
2026-03-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07254195. Inclusion in this directory is not an endorsement.